Ізраїль - іврит - Ministry of Health

cts chemical industries ltd, israel - calcium carbonate - טבליות לעיסות - calcium carbonate 500 mg - calcium carbonate - calcium carbonate - antacid, calcium supplement.

Ізраїль - іврит - Ministry of Health

cts chemical industries ltd, israel - calcium as carbonate - טבליות לעיסות - calcium as carbonate 500 mg - calcium carbonate - calcium carbonate - antacid, calcium supplement.

Ізраїль - іврит - Ministry of Health

j-c health care ltd - bosentan - טבליות מצופות פילם - bosentan 62.5 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease

Ізраїль - іврит - Ministry of Health

j-c health care ltd - bosentan - טבליות מצופות פילם - bosentan 125 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease

Ізраїль - іврит - Ministry of Health

inovamed ltd - anastrozole - טבליות מצופות פילם - anastrozole 1 mg - anastrozole - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

Ізраїль - іврит - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

Ізраїль - іврит - Ministry of Health

j-c health care ltd - miglustat - קפסולות - miglustat 100 mg - miglustat - miglustat - zavesca is indicated for the oral treatment of mild to moderate type i gaucher disease. zavesca may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable.

Ізраїль - іврит - Ministry of Health

astrazeneca (israel) ltd - ticagrelor - טבליות מצופות פילם - ticagrelor 90 mg - ticagrelor - ticagrelor - brilinta, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndromes (unstable angina, non st elevation myocardial infarction [nstemi] or st elevation myocardial infarction [stemi]); including patients managed medically, and those who are managed with percutaneous coronary intervention (pci) or coronary artery by-pass grafting (cabg).

Ізраїль - іврит - Ministry of Health

novartis israel ltd - eltrombopag as olamine - טבליות מצופות פילם - eltrombopag as olamine 25 mg - eltrombopag - eltrombopag - for the treatment of previously treated patients with chronic idiopathic thrombocytopenic purpura (itp) to increase platelet count and reduce or prevent bleeding.

Ізраїль - іврит - Ministry of Health

novartis israel ltd - eltrombopag as olamine - טבליות מצופות פילם - eltrombopag as olamine 50 mg - eltrombopag - eltrombopag - for the treatment of previously treated patients with chronic idiopathic thrombocytopenic purpura (itp) to increase platelet count and reduce or prevent bleeding.